Patient-reported Outcomes After the Treatment of Early Stage Non–small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery
Author:
Funder
Novartis Pharma
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference42 articles.
1. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up;Vansteenkiste;Ann Oncol,2014
2. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline;Videtic;Pract Radiat Oncol,2017
3. Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer;Cykert;JAMA,2010
4. Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88 studies;Zhao;Int J Radiat Oncol Biol Phys,2016
5. Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies;Chen;Int J Radiat Oncol Biol Phys,2018
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy: the Lung PLUS study;Frontiers in Oncology;2023-08-25
2. Quality of Life After Lung Cancer Surgery;Patient Reported Outcomes and Quality of Life in Surgery;2023
3. Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer;Clinical and Translational Radiation Oncology;2021-11
4. Patient-reported Outcomes With Stereotactic Body Radiotherapy and Surgery for Lung Cancer;Clinical Lung Cancer;2020-05
5. Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer;Translational Lung Cancer Research;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3